SM-164

SynDRA canonical compound SYN1049532 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	BIRC2 \| BIRC3 \| CASP3 \| CASP9 \| XIAP
Mechanism of action	XIAP inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

BIRC2
BIRC3
XIAP

Cross-references

PubChem CID: 17756618
ChEMBL: CHEMBL1774154
ChEBI: 192710

Synonyms

SM164
G2VA4GC8KB
SM-164 (pharmaceutical)
RefChem:931861
UNII-G2VA4GC8KB
SM 164 [WHO-DD]
MFCD28167763
C62H84N14O6
orb1309086
SCHEMBL9973411
CHEBI:192710
EX-A1941
BDBM50343522
AKOS030527040
SM-164?
T12932L
NCGC00263236-01
NCGC00263236-03
AC-35485
FS137718
HY-15989
MS-31985
BRD-K06191411-001-01-7
SCHEMBL30219865
BDBM50512890

Look up SM-164 in the interactive SynDRA portal →